(Q37165162)

18 August 2017

1 reference

title

Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease (English)

1 reference

18 August 2017

0 references

1 reference

B D Butts

1

1 reference

18 August 2017

C Houde

series ordinal

2

1 reference

18 August 2017

H Mehmet

series ordinal

3

1 reference

18 August 2017

publication date

16 May 2008

1 reference

Cell Death & Differentiation

18 August 2017

published in

1 reference

18 August 2017

volume

15

1 reference

18 August 2017

issue

7

1 reference

18 August 2017

page(s)

1178-1186

1 reference

The biochemistry of apoptosis

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Apaf1 is required for mitochondrial pathways of apoptosis and brain development

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Axonal control of oligodendrocyte development

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Induction of sodium channel clustering by oligodendrocytes

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Synaptic efficacy enhanced by glial cells in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

The oligodendrocyte and its many cellular processes

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Transcriptional control of oligodendrogenesis

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Notch receptor activation inhibits oligodendrocyte differentiation

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

A crucial role for p57(Kip2) in the intracellular timer that controls oligodendrocyte differentiation

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

The microenvironment of the embryonic neural stem cell: lessons from adult niches?

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

The glial identity of neural stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Microglia-derived IGF-2 prevents TNFalpha induced death of mature oligodendrocytes in vitro

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Developmentally regulated changes in c-Jun N-terminal kinase signalling determine the apoptotic response of oligodendrocyte lineage cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

FGF modulates the PDGF-driven pathway of oligodendrocyte development.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Regulation of oligodendrocyte differentiation by fibroblast growth factors

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Triiodothyronine is a survival factor for developing oligodendrocytes

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Integrin-growth factor interactions as regulators of oligodendroglial development and function

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

CNS integrins switch growth factor signalling to promote target-dependent survival

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Integrins mediate a neuronal survival signal for oligodendrocytes

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

TGF-?-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

The oligodendrocyte precursor cell in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Long-term culture of purified postnatal oligodendrocyte precursor cells. Evidence for an intrinsic maturation program that plays out over months

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

In vitro analysis of the origin and maintenance of O-2Aadult progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

NMDA receptors are expressed in oligodendrocytes and activated in ischaemia.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Expression of glutamate transporters in the adult bovine corpus callosum

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Glutamate-mediated glial injury: mechanisms and clinical importance

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Caspase-Dependent and Caspase-Independent Oligodendrocyte Death Mediated by AMPA and Kainate Receptors

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

IGF-I prevents glutamate-mediated bax translocation and cytochrome C release in O4+ oligodendrocyte progenitors

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Calcium permeability of glutamate-gated channels in the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Cloned glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Calcium-binding proteins in the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Mitochondria, oxygen free radicals, disease and ageing

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Developmental up-regulation of MnSOD in rat oligodendrocytes confers protection against oxidative injury

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Oxidative glutamate toxicity involves mitochondrial dysfunction and perturbation of intracellular Ca2+ homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Deficient peroxide detoxification underlies the susceptibility of oligodendrocyte progenitors to dopamine toxicity.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Developmental differences in HO-induced oligodendrocyte cell death: role of glutathione, mitogen-activated protein kinases and caspase 3.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Catecholamine-induced oligodendrocyte cell death in culture is developmentally regulated and involves free radical generation and differential activation of caspase-3.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Relationship of iron to oligodendrocytes and myelination

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Free radicals, mitochondria, and hypoxia-ischemia in the developing brain

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Trends in severe brain injury and neurodevelopmental outcome in premature newborn infants: the role of cystic periventricular leukomalacia

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Reduced development of cerebral cortex in extremely preterm infants

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Magnetic resonance imaging of the brain in a cohort of extremely preterm infants

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990s

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Learning disabilities in children with very low birthweight: prevalence, neuropsychological correlates, and educational interventions.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Maturation-dependent vulnerability of perinatal white matter in premature birth

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Emerging concepts in periventricular white matter injury

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Excitotoxic damage to white matter.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

NBQX attenuates excitotoxic injury in developing white matter

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Maternal infection and cerebral palsy in infants of normal birth weight

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Potentially asphyxiating conditions and spastic cerebral palsy in infants of normal birth weight

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Neonatal cytokines and cerebral palsy in very preterm infants

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Intrauterine exposure to infection and risk of cerebral palsy in very preterm infants

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Inflammatory brain damage in preterm newborns--dry numbers, wet lab, and causal inferences

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

The relationship of CSF and plasma cytokine levels to cerebral white matter injury in the premature newborn

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

The Toll-receptor family and control of innate immunity

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Do white cells matter in white matter damage?

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Effect of inflammation on central nervous system development and vulnerability

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Neuronal damage accompanies perinatal white-matter damage

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Multiple sclerosis: novel perspectives on newly forming lesions.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Childhood multiple sclerosis: a review

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Death ligands and autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

The link between excitotoxic oligodendroglial death and demyelinating diseases

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Antibodies as biological markers for pathophysiological processes in MS.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Anti-heat shock protein 90beta antibodies decrease pre-oligodendrocyte population in perinatal and adult cell cultures. Implications for remyelination in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Immune semaphorins: increasing members and their diverse roles.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Semaphorin CD100 from activated T lymphocytes induces process extension collapse in oligodendrocytes and death of immature neural cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

T-cells in neuronal injury and repair: semaphorins and related T-cell signals

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Molecular pathways of oligodendrocyte apoptosis revealed by mutations in the proteolipid protein gene

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Caspase-3 activation in oligodendrocytes from the myelin-deficient rat.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Amyloid-beta peptides are cytotoxic to oligodendrocytes.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Amyloid beta peptide-induced corpus callosum damage and glial activation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

The myelin-pathogenesis puzzle in schizophrenia: a literature review

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

The role of oligodendrocyte pathology in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.70

7 January 2021

Identifiers

DOI

10.1038/CDD.2008.70

1 reference

Dimensions Publication ID

18 August 2017

1031367763

0 references

1 reference